Saudi Arabia Blood Glucose Device Market Forecast 2025–2033
According to Renub Research Saudi Arabia Blood Glucose Device Market is expected to rise from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, expanding at a CAGR of 6.78% over 2025–2033. This growth is driven by the increasing incidence of diabetes across the Kingdom, rising public awareness about preventive health, and strong government initiatives encouraging early diagnosis and self-monitoring. Advancements in Continuous Glucose Monitoring (CGM) systems, non-invasive glucose sensors, and user-friendly glucometers are improving patient compliance and transforming diabetes management nationwide.
Saudi Arabia Blood Glucose Device Market Overview
Blood glucose devices are essential medical tools used to measure the concentration of glucose in the blood. These include glucometers, continuous glucose monitoring (CGM) systems, and flash glucose monitors, all designed to provide real-time or periodic glucose readings. Effective glucose monitoring helps prevent complications like hypoglycemia, hyperglycemia, nerve damage, kidney failure, and cardiovascular problems.
In Saudi Arabia, these devices have become increasingly important due to the country’s rising prevalence of diabetes—a major public health challenge. Sedentary lifestyles, high-calorie diets, and increasing rates of obesity have significantly contributed to the surge in Type 2 diabetes. The government has responded with awareness campaigns, early screening initiatives, and public programs that emphasize self-management.
Easy availability of blood glucose devices in pharmacies, online platforms, and hospitals, along with insurance support, is improving access for both urban and rural populations. As diabetes management increasingly shifts from hospital-centric care to home-based monitoring, demand for advanced and reliable glucose devices continues to strengthen across the Kingdom.
Request a free sample copy of the report:https://www.renub.com/request-sample-page.php?gturl=saudi-arabia-blood-glucose-device-market-p.php
Growth Drivers in the Saudi Arabia Blood Glucose Device Market
Increased Type 2 Diabetes Prevalence
Saudi Arabia ranks among the highest in global diabetes prevalence, and Type 2 diabetes is dominant among adults. Sedentary routines, unhealthy diet patterns, and high BMI levels are primary contributors. Growing public awareness, along with recommendations from healthcare providers, has encouraged regular glucose testing among diagnosed and at-risk individuals.
According to recent IDF findings:
- 27 million people in Saudi Arabia currently have diabetes.
- An additional 86 million individuals are estimated to be undiagnosed.
- Diabetes cases are projected to reach 6 million by 2030 and 7.5 million by 2045.
This growing disease burden increases the demand for both traditional glucometers and advanced CGM systems. As early diagnosis and long-term management gain more attention, the blood glucose device market is expected to remain on a steady growth trajectory.
Technological Advancements and User-Friendly Devices
Modern blood glucose devices are becoming more portable, more accurate, and significantly easier to use. Innovations such as smartphone-enabled glucometers, Bluetooth connectivity, cloud-based data storage, and painless, needle-free monitoring are revolutionizing patient experience.
CGM systems provide continuous readings, trend charts, and predictive alerts, enabling patients to control glucose fluctuations with far greater accuracy. These advanced features especially benefit children, the elderly, and Type 1 diabetic patients who require close monitoring.
A milestone occurred in August 2023, when Nemaura Medical received SFDA approval for its non-invasive sugarBEAT glucose sensor. This CE-marked wearable provides full-day glucose insights without finger pricking, offering a convenient alternative for patients seeking a painless monitoring method.
As international brands enter the Saudi market with cutting-edge devices, consumers gain access to better tools that promote compliance and long-term disease management.
Government Programs and Public Health Campaigns
Vision 2030 places strong emphasis on prevention, early diagnosis, and chronic disease management. Government-led diabetes campaigns, mobile screening units, school health programs, and healthcare collaborations have boosted public awareness.
Insurance coverage, subsidies, and nationwide screening initiatives have made glucose devices more accessible, especially to newly diagnosed patients in hospitals and primary healthcare centers.
In 2024, the Saudi Ministry of Health partnered with Ithnain to launch a digital coaching program for over 10,000 diabetic patients, supporting personalized guidance, continuous monitoring, and early intervention. Such initiatives align with Saudi Arabia’s goal of reducing lifestyle-related diseases and improving national health outcomes.
These strategic reforms significantly accelerate device adoption across all demographics and regions.
Obstacles in the Saudi Arabia Blood Glucose Device Market
Excessive Cost of Sophisticated Devices
Despite the benefits of advanced CGM systems and smart glucometers, high costs remain a major barrier. Premium devices—particularly imported CGMs or Bluetooth-enabled monitors—often fall outside the affordability of low- to middle-income families.
Inconsistent insurance coverage results in many patients relying solely on traditional glucometers or outdated devices. Without broader subsidies, the adoption of advanced glucose monitoring technologies may grow slowly in price-sensitive segments.
Limited Compliance and Awareness in Rural Regions
While healthcare accessibility is strong in major cities, awareness gaps and educational limitations persist in rural and remote regions. Many individuals lack understanding of the importance of frequent glucose monitoring or the proper use of devices. Others may be hesitant or unfamiliar with newer technologies like mobile-connected monitors.
This urban-rural imbalance affects early diagnosis and long-term disease control. Expanding outreach programs and healthcare education in rural areas is key to achieving uniform adoption across the Kingdom.
Saudi Arabia Blood Glucose Device Market for Test Strips
Test strips make up one of the largest spending categories in glucose monitoring. They are widely used with traditional glucometers and remain the preferred choice for many elderly and Type 2 diabetic patients due to affordability and simplicity.
However, recurring expenses can become a burden for long-term users, especially if insurance coverage is limited. The market includes a wide variety of strips compatible with different glucometer models, supplied by both multinational and regional manufacturers.
The consistent and ongoing demand for test strips plays an essential role in supporting the overall growth of the blood glucose device market in Saudi Arabia.
Saudi Arabia Type 2 Diabetes Blood Glucose Device Market
Type 2 diabetes constitutes the majority of diabetes cases in Saudi Arabia, making it the most significant driver of glucose device consumption. Patients require regular monitoring to track glucose fluctuations, adjust medications, and prevent complications.
Devices designed for ease-of-use—featuring large displays, voice guidance, and low blood sample requirements—are especially popular among older adults. Growing encouragement from healthcare providers to adopt home monitoring further boosts demand. As chronic disease programs expand across public and private clinics, the market for Type 2 diabetes monitoring devices is expected to grow steadily.
Saudi Arabia Blood Glucose Device Hospital Pharmacies Market
Hospital pharmacies are crucial distribution channels, especially for newly diagnosed patients requiring immediate device access. Here, patients receive hands-on demonstrations and professional counseling, ensuring proper device usage.
Public hospitals often provide subsidized or free devices to eligible patients, ensuring equitable access. With rising hospital admissions related to diabetic complications, hospital pharmacies continue to play a vital role in educating patients and improving compliance.
Saudi Arabia Blood Glucose Device Retail Pharmacies Market
Retail pharmacies dominate glucose device sales due to convenience, broad product availability, and frequent promotional offers. Major pharmacy chains such as Al Nahdi, Al-Dawaa, and White Pharmacy stock various brands, ranging from basic glucometers to advanced CGM systems.
Pharmacists routinely guide customers in selecting suitable devices and understanding testing procedures. Expansion of pharmacy branches into smaller towns, combined with home delivery services and online ordering, is driving rapid growth in this channel.
Dhahran Blood Glucose Device Market
Dhahran, located in the Eastern Province, is a major hub for high-quality healthcare services and affluent consumers. The city shows high adoption of advanced glucose monitoring systems, including CGMs and wearable sensors. Hospitals and specialty clinics in Dhahran are equipped with cutting-edge technologies, and awareness levels are significantly high.
Continuous educational programs organized by healthcare providers and local institutions further strengthen the city’s leadership in diabetes management solutions.
Riyadh Blood Glucose Device Market
As the capital and largest city, Riyadh represents the biggest and most dynamic market for blood glucose devices in Saudi Arabia. With top-tier hospitals, diabetes centers, and diagnostic laboratories, the city remains at the forefront of early detection and advanced monitoring.
Urban consumers, including younger demographics, show increasing interest in smart, app-connected devices. Riyadh’s tech-savvy population and strong private healthcare sector make it a centerpiece for innovation and market expansion.
Jeddah Blood Glucose Device Market
Jeddah is another fast-growing urban center experiencing rising lifestyle-related diseases. The city’s diverse population creates demand for a broad range of glucose devices—from basic models to advanced wearable CGMs. Hospitals, retail pharmacies, and wellness programs in Jeddah play an active role in promoting early diagnosis and self-monitoring.
Digital health advancements and large-scale awareness initiatives make Jeddah a strategic region for manufacturers and distributors seeking market penetration.
Market Segmentation
Product
- Test Strips
- Lancets
- Blood Glucose Meters
Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
End User
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Diabetes Clinics & Centers
Top States
- Dhahran
- Riyadh
- Khobar
- Jeddah
- Dammam
- Others
Key Company Profiles
Major companies shaping the Saudi Arabia Blood Glucose Device Market include:
- Abbott Laboratories
- Medtronic
- Dexcom Inc.
- Braun Melsungen AG
- DarioHealth Corp
- Sanofi
- Bionime Corporation
- Novo Nordisk
These companies drive competition through digital integration, non-invasive monitoring technologies, improved accuracy, and user-friendly designs.